organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2021 Filed Jul 6, 2021 17:05 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 50,075 | $233.58 | $11,696,268.13 |
DisclosureSEC source: 0001209191-21-045315 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,201,400 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.09 to $234.06, inclusive. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 17:05 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 147,727 | $232.69 | $34,374,743.36 |
DisclosureSEC source: 0001209191-21-045315 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,251,475 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.09 to $233.085, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 17:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,200 | $238.13 | $285,757.20 |
DisclosureSEC source: 0001209191-21-043246 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,399,202 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.0075 to $238.27, inclusive. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 17:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 11,698 | $237.45 | $2,777,643.31 |
DisclosureSEC source: 0001209191-21-043246 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,400,402 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 600 | $235.67 | $141,400.80 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,412,100 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices of $235.665 and $235.68, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 42,596 | $235.15 | $10,016,534.59 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,412,700 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.65 to $235.645, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 57,008 | $233.89 | $13,333,487.10 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,455,296 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.635 to $234.63, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 120,475 | $233.17 | $28,091,637.65 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,512,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.635 to $233.63, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 14:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 19,321 | $232.35 | $4,489,292.31 |
DisclosureSEC source: 0001209191-21-039767 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,632,779 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.635 to $232.63, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 19:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 870 | $226.36 | $196,933.20 |
DisclosureSEC source: 0001209191-21-039422 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,652,100 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.3333 to $226.39, inclusive. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 19:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 84,516 | $225.64 | $19,069,767.66 |
DisclosureSEC source: 0001209191-21-039422 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,652,970 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.27 to $226.26, inclusive. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 19:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 74,766 | $224.93 | $16,817,415.44 |
DisclosureSEC source: 0001209191-21-039422 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,737,486 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.27 to $225.2681, inclusive. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 19:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 59,848 | $223.90 | $13,400,146.74 |
DisclosureSEC source: 0001209191-21-039422 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,812,252 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.27 to $224.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 600 | $233.23 | $139,936.20 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 15 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,872,100 F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices of $232.91 and $233.29. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,100 | $232.03 | $255,229.70 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 14 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,872,700 F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.89 to $232.88, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,164 | $231.36 | $1,426,084.55 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 13 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,873,800 F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.87 to $231.86, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 15,125 | $230.14 | $3,480,928.00 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 12 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,879,964 F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.85 to $230.79, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 17,321 | $229.46 | $3,974,459.34 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 11 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,895,089 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.83 to $229.82, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,700 | $228.38 | $1,530,139.30 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,912,410 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.83 to $228.8247, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,010 | $227.27 | $2,275,012.74 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,919,110 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.79 to $227.777, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,627 | $226.33 | $2,405,177.03 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,929,120 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.7467 to $226.74, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 21,187 | $225.17 | $4,770,634.42 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,939,747 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.7442 to $225.73, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 33,646 | $224.27 | $7,545,822.07 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,960,934 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.743 to $224.74, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 46,716 | $223.17 | $10,425,796.58 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,994,580 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.73 to $223.7293, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 29,489 | $222.40 | $6,558,206.16 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,041,296 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.7003 to $222.70, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 14,621 | $221.12 | $3,232,966.28 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,070,785 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.61 to $221.54, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,625 | $220.36 | $1,239,519.38 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,085,406 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.6005 to $220.60, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 11,069 | $219.09 | $2,425,096.14 |
DisclosureSEC source: 0001209191-21-038854 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,091,031 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.60 to $219.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), and (15) to this Form 4. Read SEC document |
| May 24, 2021 Filed May 25, 2021 14:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,292 | $203.25 | $262,597.71 |
DisclosureSEC source: 0001209191-21-035631 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,102,100 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.07 to $203.46, inclusive. Read SEC document |
| May 24, 2021 Filed May 25, 2021 14:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,010 | $202.33 | $609,022.33 |
DisclosureSEC source: 0001209191-21-035631 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,103,392 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.00 to $202.89, inclusive. Read SEC document |
| May 24, 2021 Filed May 25, 2021 14:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,027 | $201.78 | $610,785.03 |
DisclosureSEC source: 0001209191-21-035631 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,106,402 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| May 21, 2021 Filed May 24, 2021 15:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 28,504 | $201.30 | $5,737,912.21 |
DisclosureSEC source: 0001209191-21-035188 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,109,429 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.885, inclusive. Read SEC document |
| May 21, 2021 Filed May 24, 2021 15:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 64,236 | $200.26 | $12,864,094.07 |
DisclosureSEC source: 0001209191-21-035188 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,137,933 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,200 | $201.01 | $442,219.80 |
DisclosureSEC source: 0001209191-21-034809 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,202,169 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.035, inclusive. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 97,731 | $200.46 | $19,591,547.18 |
DisclosureSEC source: 0001209191-21-034809 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,204,369 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.9925, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,726 | $211.90 | $365,741.13 |
DisclosureSEC source: 0001209191-21-019413 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,302,100 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.82 to $212.04, inclusive. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,720 | $211.13 | $1,629,946.76 |
DisclosureSEC source: 0001209191-21-019413 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,303,826 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.80 to $211.60, inclusive. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 17,270 | $210.28 | $3,631,501.06 |
DisclosureSEC source: 0001209191-21-019413 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,311,546 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.80 to $210.77, inclusive. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 33,243 | $209.12 | $6,951,842.65 |
DisclosureSEC source: 0001209191-21-019413 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,328,816 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.80 to $209.79, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 17:26 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 60,874 | $210.12 | $12,790,723.13 |
DisclosureSEC source: 0001209191-21-018870 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,362,059 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.8037 to $210.7578, inclusive. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 17:26 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 64,410 | $209.29 | $13,480,368.90 |
DisclosureSEC source: 0001209191-21-018870 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,422,933 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.80 to $209.79, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 18:04 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 148,766 | $191.14 | $28,435,579.54 |
DisclosureSEC source: 0001209191-21-003958 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,487,343 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.83 to $191.6538 , inclusive. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 18:04 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 41,298 | $190.49 | $7,866,897.32 |
DisclosureSEC source: 0001209191-21-003958 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,636,109 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.83 to $190.829, inclusive. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 18:04 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 24,936 | $189.30 | $4,720,384.80 |
DisclosureSEC source: 0001209191-21-003958 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,677,407 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.80 to $189.7949, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 16:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 9,722 | $187.12 | $1,819,190.36 |
DisclosureSEC source: 0001209191-21-003538 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,702,343 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.00 to $187.58, inclusive. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 16:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 95,353 | $186.47 | $17,780,569.26 |
DisclosureSEC source: 0001209191-21-003538 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,712,065 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.00 to $186.995, inclusive. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 16:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 104,925 | $185.40 | $19,453,304.85 |
DisclosureSEC source: 0001209191-21-003538 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,807,418 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.00 to $185.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| January 11, 2021 Filed Jan 12, 2021 16:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 300 | $187.46 | $56,237.10 |
DisclosureSEC source: 0001209191-21-003183 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,912,343 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.45 to $187.46, inclusive. Read SEC document |
| January 11, 2021 Filed Jan 12, 2021 16:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 48,871 | $187.00 | $9,138,681.52 |
DisclosureSEC source: 0001209191-21-003183 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,912,643 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.44 to $187.43, inclusive. Read SEC document |
| January 11, 2021 Filed Jan 12, 2021 16:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 42,301 | $185.63 | $7,852,250.03 |
DisclosureSEC source: 0001209191-21-003183 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,961,514 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.44 to $186.435, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.